Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for non-LVO ischemic stroke (EXTEND-IV)
NCT05199662Phase 3Recruiting
- Sponsor
- Hospital Moinhos de Vento
- Start
- Jan 2022
- Primary completion
- Jul 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Hospital Moinhos de Vento. Started Jan 2022; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05199662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199662.